The US Bankruptcy Court gave an order approving the sale of the certain assets of Rock Creek Pharmaceuticals, Inc. on January 11, 2018. The debtor has been authorized to sell its certain assets to Philip Morris Products, S.A for a purchase price of $0.24 million. The debtor’s assets include intellectual property. Under the terms of the asset purchase agreement, the buyer would be entitled to a break-up fee of $0.02 million and expense reimbursement in case of termination of the asset purchase agreement.